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Hybrid PET/MRI systems have recently become commer-
cially available with potential to change medical imaging
by providing combined anatomical-metabolic image
information. Especially in cancer patients, this may be of
benefit.
PET itself is widely used in everyday routine due to its
capability of providing molecular information used mainly
for the non-invasive characterization of tumors and
metastases [1,2], as well as for monitoring effect of cancer
therapy [3]. However, PET images contain no detailed
anatomical information and, therefore benefits from fusion
with morphological image information from CT.
Accordingly, since PET/CT systems became available
oncological PET examinations have mainly been
performed as combined PET/CT which has been proven
of higher diagnostic value than separate PET or CT
imaging in a number of clinical indications [4]. Recently,
hybrid PET/MRI scanners were introduced and made
available. However, PET/MRI is more costly and with a
lower throughput than PET/CT. Accordingly, the question
arises when and if PET/MRI should be used in cancer
patients. MRI has the advantages compared to CT, that it
may also be considered a functional imaging technique in
addition to its anatomical capabilities. This may be of
particular relevance in cancer patients in view of need for
planning tailored therapy and for monitoring response to
treatment [5,6]. Compared to CT, also the anatomical
capabilities of MRI are often superior due to better soft-
tissue contrast.
The knowledge obtained from molecular imaging-
guided therapies e.g. using FDG-PET for predicting
therapy response in lymphomas [7], could quickly be
transferred to PET/MRI, for a combined multi-parametric
strategy. Accordingly, hybrid PET/MRI scanners might
become game-changers for how MRI is used in clinical
routine.
At the Department of Clinical Physiology, Nuclear
Medicine & PET at Rigshospitalet in Copenhagen we have
currently PET/MRI scanned more than 1,200 patients and
our experience so far will be presented and discussed with
focus on whether PET/MRI fulfills a real clinical need
within oncology or should (still) be considered an
expensive research tool and the challenges of PET/
MRI [8,9].
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